Cat.#: ACPP-1198
| Despition | PDE6 Alpha Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1665 | Human CDK5 Protein (AC1665) | 5 µg | inquiry |
| ACPP-1234 | SOX10 Blocking Peptide (AC1234) | 250 µg | inquiry |
| ACPP-1136 | TYRO3 Blocking Peptide (AC1136) | 250 µg | inquiry |
| ACPP-1391 | Human Apo D Protein (AC1391) | 2 µg | inquiry |
| ACPP-1288 | C9orf72 Blocking Peptide (AC1288) | 250 µg | inquiry |
| ACPP-1046 | Recombinant Mouse CD45 Protein (6×His Tag) (AC1046) | 50 µg | inquiry |
| ACPP-1596 | Human SPG21 Protein (AC1596) | 5 µg | inquiry |
| ACPP-1278 | EAAT1 Blocking Peptide (AC1278) | 250 µg | inquiry |
| ACPP-1634 | NDK E.Coli (AC1634) | 5 µg | inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.